The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
In Vivo D2 Dopamine Receptor Density in Psychotic and Nonpsychotic Patients With Bipolar Disorder
Abstract
BACKGROUND: A prior positron emission tomographic study from The Johns Hopkins University, Baltimore, Md, using N-methylspiperone labeled with carbon 11 reported elevated basal ganglia D2 dopamine receptor density (Bmax) values in neuroleptic-naive schizophrenic patients compared with controls. We have now extended these studies to include patients with bipolar disorder. METHODS: Patients with bipolar disorder (n = 14) either had never received neuroleptic medication or had been neuroleptic-free for more than 6 months, and they met DSM-III criteria for currently symptomatic affective disorder. Patients with bipolar disorder were compared with matched schizophrenic patients and normal controls. All received two positron emission tomographic scans, the second of which was preceded by oral administration of haloperidol lactate, to permit the calculation of D2 dopamine receptor Bmax. RESULTS: Diagnostic groups differed in Bmax by analysis of variance (P < .0001); post hoc tests showed higher Bmax values for psychotic patients with bipolar disorder and schizophrenic patients compared with normal controls and for schizophrenic patients and psychotic patients with bipolar disorder compared with nonpsychotic patients with bipolar disorder. Among patients with bipolar disorder, Bmax values correlated significantly with the severity of psychotic symptoms (r = .63) on the Present State Examination but not with the severity of nonpsychotic mood symptoms. CONCLUSIONS: We conclude that, like schizophrenic patients, patients with psychotic bipolar disorder have elevations of D2 dopamine receptor Bmax values and that such elevations in affective disorder are more closely associated with the presence of psychosis than with mood abnormality. Elevations in dopamine receptor values thus may occur in psychiatric states that are characterized by psychotic symptoms rather than being specific to schizophrenia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is also evidence that the presence of psychosis may moderate patterns of DA receptor binding. Specifically, striatal D2 receptor signaling seems to be greater in psychotic patients with bipolar disorder [286,287], whereas no differences in D2 availability were found between non-psychotic patients with bipolar disorder and controls [288,289].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [286]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744
Book Review: Measurement and Classification of Psychiatric Symptoms
Priest, R. G. (1975) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591577506800751 · Cited by 2,268
Positron Emission Tomography Reveals Elevated D 2 Dopamine Receptors in Drug-Naive Schizophrenics
Wong, D. F., Wagner, H. N., Tune, L. E., Dannals, R. F., Pearlson, G. D., Links, J. M., Tamminga, C. A., Broussolle, E., Ravert, H. T., Wilson, A. A., et al. (1986) · Science · doi:10.1126/science.2878495 · Cited by 928
Self-citationWong, D. F., Wagner, H. N., Dannals, R. F., Links, J. M., Frost, J. J., Ravert, H. T., Wilson, A. A., Rosenbaum, A. E., GJEDDE, A. H., Douglass, K. H., et al. (1984) · Science · doi:10.1126/science.6334363 · Cited by 700
Swerdlow, N. R., & Koob, G. F. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00047488 · Cited by 674
Diagnosis in Schizophrenia and Manic-Depressive Illness
Pope, H. G. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770310017001 · Cited by 630
Dopamine D4 receptors elevated in schizophrenia
Seeman, P. M., Guan, H., & Tol, H. H. M. V. (1993) · Nature · doi:10.1038/365441a0 · Cited by 627
Cerebral Metabolic Rates for Glucose in Mood Disorders
Baxter, L. R. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790280019002 · Cited by 602
Zur Serotonin-Hypothese der Depression*
Lesch, K., & Beckmann, H. (1990) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/s-2007-1001206 · Cited by 392
Buchsbaum, M. S., Wu, J. C., DeLisi, L. E., Holcomb, H. H., KESSLER, R. M., Johnson, J., King, A. C., Hazlett, E., Langston, K. C., & Post, R. M. (1986) · Journal of Affective Disorders · doi:10.1016/0165-0327(86)90036-4 · Cited by 368
No D2 Receptor Increase in PET Study of Schizophrenia
Farde, L. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190091013 · Cited by 293
Dopamine D2 receptors in depression measured with single photon emission computed tomography
D'haenen, H. A., & Bossuyt, A. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)91202-5 · Cited by 189
THE NORTHWICK PARK "FUNCTIONAL" PSYCHOSIS STUDY: DIAGNOSIS AND TREATMENT RESPONSE
Johnstone, E., Frith, C., Crow, T., & Owens, D. C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90682-4 · Cited by 187
EFFECTS OF d‐ AND l‐AMPHETAMINE ON LOCAL CEREBRAL GLUCOSE UTILIZATION IN THE CONSCIOUS RAT 1
Wechsler, L. R., Savaki, H., & Sokoloff, L. (1979) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1979.tb04504.x · Cited by 185
Buchsbaum, M. S., Wu, J. C., DeLisi, L. E., Holcomb, H. H., Hazlett, E. A., Langston, K. C., & KESSLER, R. M. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90170-3 · Cited by 181
Behavioral and biochemical effects ofl-DOPA after peripheral decarboxylase inhibition
Butcher, L. L., & Engel, J. A. (1969) · Brain Research · doi:10.1016/0006-8993(69)90322-9 · Cited by 172
Serotonin-dopamine interactions in the nigrostriatal system
Waldmeier, P. C., & Delini‐Stula, A. (1979) · European Journal of Pharmacology · doi:10.1016/0014-2999(79)90110-9 · Cited by 171
Neuroanatomical Studies of Major Affective Disorders
Jeste, D. V., Lohr, J. B., & Goodwin, F. K. (1988) · The British Journal of Psychiatry · doi:10.1192/bjp.153.4.444 · Cited by 130
Pathology, Phenomenology and the Dopamine Hypothesis of Schizophrenia
McKenna, P. J. (1987) · The British Journal of Psychiatry · doi:10.1192/bjp.151.3.288 · Cited by 129
Manic patients with schizophrenic or paranoid symptoms
Brockington, I., Wainwright, S., & Kendell, R. E. (1980) · Psychological Medicine · doi:10.1017/s0033291700039611 · Cited by 124
The distribution of alterations in energy metabolism in the rat brain produced by apomorphine
McCulloch, J., Savaki, H. E., McCulloch, M. C., Jehle, J. W., & Sokoloff, L. (1982) · Brain Research · doi:10.1016/0006-8993(82)91121-0 · Cited by 112
Tune, L. E., Wong, D. F., Pearlson, G. D., Strauss, M. E., YOUNG, T. J. K., Shaya, E. K., Dannals, R. F., Wilson, A. A., Ravert, H. T., Sapp, J., et al. (1993) · Psychiatry Research · doi:10.1016/0165-1781(93)90063-m · Cited by 100
Self-citationA new scale for measuring mania
Blackburn, I. M., Ashworth, C. M., & Loudon, J. B. (1977) · Psychological Medicine · doi:10.1017/s0033291700004438 · Cited by 96
Development of a schizophrenia scale sensitive to change
Montgomery, S., Taylor, P. J., & Montgomery, D. (1978) · Neuropharmacology · doi:10.1016/0028-3908(78)90038-2 · Cited by 90
Dopamine in manic depressive illness
Silverstone, T. (1985) · Journal of Affective Disorders · doi:10.1016/0165-0327(85)90020-5 · Cited by 77
Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants.
Ch, C., Pg, J., Jm, D., Altman, E., Andriukaitis, S. M., & Hedeker, D. (1987) · PubMed · Cited by 75
RESPONSE TO BROMOCRIPTINE DISTINGUISHES BIPOLAR FROM UNIPOLAR DEPRESSION
Silverstone, T. (1984) · The Lancet · doi:10.1016/s0140-6736(84)91359-x · Cited by 66
Double‐blind comparative clinical trial of pimozide and chlorpromazine in mania
Cookson, J., Silverstone, T., & Wells, B. (1981) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1981.tb00797.x · Cited by 58
Inhibition of Dopamine-B-Hydroxylase in Manic Patients
Sack, R. L. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760170049008 · Cited by 56
Wyatt, R. J., & Torgow, J. S. (1977) · Journal of Psychiatric Research · doi:10.1016/0022-3956(77)90011-5 · Cited by 52
Silverstone, T., Fincham, J., Wells, B., & Kyriakides, M. (1980) · Neuropharmacology · doi:10.1016/0028-3908(80)90215-4 · Cited by 44
Major psychosis and dopamine: controversial features and some suggestions
Miller, R. J. (1984) · Psychological Medicine · doi:10.1017/s0033291700019759 · Cited by 43
Low neuroleptic serum levels in patients receiving fluphenazine decanoate
Tune, L. E., Creese, I., COYLE, J. T., Pearlson, G. D., & Snyder, S. H. (1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.1.80 · Cited by 35
Self-citationWong, D. F., Wagner, H. N., Dannals, R. F., Links, J. M., Frost, J. J., Ravert, H. T., Wilson, A. A., Rosenbaum, A. E., GJEDDE, A. H., Douglass, K. H., et al. (1985) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-198505000-00081 · Cited by 34
Nolen, W. A. (1983) · Journal of Affective Disorders · doi:10.1016/0165-0327(83)90001-0 · Cited by 32
The Dopamine Hypothesis Survives, but There Must Be a Way Ahead
Crow, T. J. (1987) · The British Journal of Psychiatry · doi:10.1192/bjp.151.4.460 · Cited by 29
Linnoila, M. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800320011001 · Cited by 20
Depression and neurological disorders
Folstein, M. F., Robinson, R., Folstein, S., & McHugh, P. R. (1985) · Journal of Affective Disorders · doi:10.1016/0165-0327(85)90083-7 · Cited by 17
Cited by
Sorted by citations
Kapur, S. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.13 · Cited by 2,813
Neuroimaging studies of mood disorders
Drevets, W. C. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01020-9 · Cited by 1,334
The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings
Strakowski, S. M., DelBello, M. P., & Adler, C. M. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001585 · Cited by 818
Vulnerability to psychopathology: A biosocial model.
Zuckerman, M. (1999) · American Psychological Association eBooks · doi:10.1037/10316-000 · Cited by 620
Ashok, A. H., Marques, T. R., Jauhar, S., Nour, M. M., Goodwin, G. M., Young, A. H., & Howes, O. D. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.16 · Cited by 546
Metadata
- Authors
- Pearlson, G. D.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Pearlson, Godfrey D.
- ORCID
- Pearlson, Godfrey D.
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 1995-06-01
- Volume
- 52
- Issue
- 6
- Pages
- 471
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2138538568
- Cited by
- 235
- References
- 42
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 6 · 2021: 27 · 2020: 3 · 2019: 4 · 2018: 3 · 2017: 7 · 2016: 6 · 2015: 4 · 2014: 13 · 2013: 6 · 2012: 15
- FWCI
- 7.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of General Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01mh040391-02, 5r01mh042821-07)
- National Institute of Mental Health (MH 42821, MH-40391, MH43775)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- bipolar disorder, psychosis, schizophrenia, basal ganglia, neuroleptic-naive patients, psychotic symptom severity, dopamine receptor binding
- MeSH terms
- Adult, Bipolar Disorder, Brain, Carbon Radioisotopes, Caudate Nucleus, Female, Haloperidol, Humans, Male, Middle Aged, Psychiatric Status Rating Scales, Psychotic Disorders, Putamen, Receptors, Dopamine, Schizophrenia, Spiperone, Tomography, Emission-Computed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review